Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications
Cancer Jul 23, 2019
Sasaki CT, et al. - In this pilot study, researchers analyzed NF-κB–related messenger RNA (mRNA) and microRNA oncogenic phenotypes in bile-related human hypopharyngeal squamous cell carcinoma (HSCC), similar to those earlier recognized in acidic bile–exposed premalignant murine hypopharyngeal mucosa. An intense NF-κB activation along with significant overexpression of RELA(p65), EGFR, STAT3, BCL-2, cREL, ΔNp63, WNT5A, IL-6, and IL1B; upregulation of oncomir miR-21; and downregulation of tumor suppressor miR-375 was shown by bile(+) HSCC vs their respective adjacent normal tissues (ANTs). Significantly higher mRNA levels were shown by bile(+) HSCC of all the analyzed genes, especially RELA(p65), IL-6, EGFR, and TNF-α than bile(-) tumors. In bile(+) HSCCs vs their ANTs and bile(-) tumors, >260-fold and >30-fold higher miR-21/miR-375 ratio, which earlier has been associated with tumor aggressiveness, was found, respectively. According to novel findings, a history of bile as a part of esophageal reflux disease could independently confer risk for hypopharyngeal carcinogenesis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries